Lysophosphatidylcholine increases endothelial permeability: Role of PKCα and RhoA cross talk

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 2 33-2, 2005, Pages

  Huang, Fei ^a   Subbaiah, Papasani V ^b   Holian, Oksana ^c   Zhang, Jihang ^a   Johnson, Arnold ^d   Gertzberg, Nancy ^d   Lum, Hazel ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Jr Hospital of Cook County   (United States)

^d STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Protein kinase C; Signal transduction

Indexed keywords

GUANOSINE TRIPHOSPHATE; LYSOPHOSPHATIDYLCHOLINE; PROTEIN KINASE C ALPHA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RNA;

ANIMAL CELL; ARTICLE; CATTLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CAPILLARY PERMEABILITY; CATTLE; CDC42 GTP-BINDING PROTEIN; CELL SURVIVAL; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GUANOSINE TRIPHOSPHATE; HUMANS; LUNG; LYSOPHOSPHATIDYLCHOLINES; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN TRANSPORT; RAC1 GTP-BINDING PROTEIN; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SKIN;

EID: 22444437847     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00003.2005     Document Type: Article

References (40)

1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, and Lawley TJ. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690, 1992.
2. 2 in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 257: L430-L437, 1989.
3. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, and Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 273: 21867-21874, 1998.
4. Ferro T, Neumann P, Gertzberg N, Clements R, and Johnson A. Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol 278: L1107-L1117, 2000.
5. Katz AM and Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48: 1-16, 1981.
6. Kim K, Ren J, Jiang Y, Ebrahem Q, Tipps R, Cristina K, Xiao Y, Qiao J, Taylor KL, Lum H, Anand-Apte B, and Xu Y. GPR4 plays critical role in endothelial cells and mediates the effects of sphingosylphosphorylcholine. FASEB J. 19: 819-821, 2005.
7. Kugiyama K, Sugiyama S, Ogata N, Oka H, Doi H, Ota Y, and Yasue H. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143: 201-204, 1999.
8. Kume N, Cybulsky MI, and Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90: 1138-1144, 1992.
9. Lerm M, Schmidt G, and Aktories K. Bacterial protein toxins targeting rho GTPases. FEMS Microbiol Lett 188: 1-6, 2000.
10. Liu JP. Protein kinase C and its substrates. Mol Cell Endocrinol 116: 1-29, 1996.
11. Lum H, Hao Z, Gayle D, Kumar P, Patterson CE, and Uhler MD. Vascular endothelial cells express isoforms of protein kinase A inhibitor. Am J Physiol Cell Physiol 282: C59-C66, 2002.
12. Lum H, Jaffe HA, Schulz IT, Masood A, RayChaudhury A, and Green RD. Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Am J Physiol Cell Physiol 277: C580-C588, 1999.
13. Lum H, Podolski JL, Gurnack ME, Schulz IT, Huang F, and Holian O. Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 281: L546-L555, 2001.
14. Lum H, Qiao J, Walter RJ, Huang F, Subbaiah PV, Kim KS, and Holian O. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am J Physiol Heart Circ Physiol 285: H1786-H1789, 2003.
15. Marinetti GV. Chromatographic separation, identification, and analysis of phosphatides. J Lipid Res 3: 1-20, 1962.
16. McHowat J and Corr PB. Thrombin-induced release of lysophosphatidylcholine from endothelial cells. J Biol Chem 268: 15605-15610, 1993.
17. Mcintyre TM, Zimmerman GA, and Prescott SM. Biologically active oxidized phospholipids. J Biol Chem 274: 25189-25192, 1999.
18. 2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 142: 157-161, 1990.
19. Mehta D, Rahman A, and Malik AB. Protein kinase C-α signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 276: 22614-22620, 2001.
20. Moy AB, VanEngelenhoven J, Bodmer J, Kamath J, Keese C, Giaever I, Shasby S, and Shasby DM. Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J Clin Invest 97: 1020-1027, 1996.
21. Murohara T, Scalia R, and Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 78: 780-789, 1996.
22. Murphy AA, Santanam N, Morales AJ, and Parthasarathy S. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab 83: 2110-2113, 1998.
23. Murugesan G, Sandhya Rani MR, Gerber CE, Mukhopadhyay C, Ransohoff RM, Chisolm GM, and Kottke-Marchant K. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol 35: 1375-1384, 2003.
24. Nagpala PG, Malik AB, Vuong PT, and Lum H. Protein kinase C β 1 verexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 166: 249-255, 1996.
25. Okita M, Gaudette DC, Mills GB, and Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients. Int J Cancer 71: 31-34, 1997.
26. Ousman SS and David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30: 92-104, 2000.
27. Parekh DB, Ziegler W, and Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J 19: 496-503, 2000.
28. Portman OW and Illingworth DR. Lysolecithin binding to human and squirrel monkey plasma and tissue components. Biochim Biophys Acta 326: 34-42, 1973.
29. Qiao J, Huang F, and Lum H. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284: L972-L980, 2003.
30. Ryborg AK, Deleuran B, Sogaard H, and Kragballe K. Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta Derm Venereol 80: 242-246, 2000.
31. 2 in the isolated human umbilical vein. Br J Pharmacol 131: 145-151, 2000.
32. Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, and Klein MS. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 62: 546-553, 1978.
33. Sugiyama S, Kugiyama K, Ogata N, Doi H, Ota Y, Ohgushi M, Matsumura T, Oka H, and Yasue H. Biphasic regulation of transcription factor nuclear factor-κB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 18: 568-576, 1998.
34. 2 expression and inflammation: the relationship with associated disease states. J Lipid Mediators 8: 1-30, 1993.
35. Van Nieuw Amerongen GP, Draijer R, Vermeer MA, and van Hinsbergh VW. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res 83: 1115-1123, 1998.
36. Vuong TD, Braam B, Willekes-Koolschijn N, Boer P, Koomans HA, and Joles JA. Hypoalbuminaemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 18: 1485-1492, 2003.
37. Wysolmerski RB and Lagunoff D. Regulation of permeabilized endothelial cell retraction by myosin phosphorylation. Am J Physiol Cell Physiol 261: C32-C40, 1991.
38. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, and King GL. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1996.
39. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 1582: 81-88, 2002.
40. Zhu Y, Lin JH, Liao HL, Verna L, and Stemerman MB. Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345: 93-98, 1997.